Health Care & Life Sciences » Pharmaceuticals | Shijiazhuang Yiling Pharmaceutical Co. Ltd.

Shijiazhuang Yiling Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Shijiazhuang Yiling Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Nanfang CSI 500 ETF
2,038,954
0.21%
-137,000
0.19%
12/31/2017
1,074,113
0.11%
-720,534
0.44%
12/31/2017
893,711
0.09%
-151,309
0.79%
12/31/2017
572,082
0.06%
0
1.18%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
329,061
0.03%
0
0%
07/31/2018
292,108
0.03%
27,000
0.41%
12/31/2017
278,405
0.03%
-68,500
0.48%
12/31/2017
252,000
0.03%
252,000
0.98%
12/31/2017
GF CSI 500 ETF
164,097
0.02%
-35,500
0.19%
12/31/2017
131,175
0.01%
-60,100
0.09%
12/31/2017

About Shijiazhuang Yiling Pharmaceutical Co.

View Profile
Address
No. 238 Tianshan Avenue
Shijiazhuang Hebei 050035
China
Employees -
Website http://www.yiling.cn
Updated 07/08/2019
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the pharmaceutical manufacturing. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products. The company was founded by Yi Ling Wu in August 28, 2001 and is headquartered in Shijiazhuang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.